key: cord-0919758-u7gbzyvx
authors: Iftimie, Simona; López-Azcona, Ana F.; Vicente-Miralles, Manuel; Descarrega-Reina, Ramon; Hernández-Aguilera, Anna; Riu, Francesc; Simó, Josep M.; Garrido, Pedro; Joven, Jorge; Camps, Jordi; Castro, Antoni
title: Risk factors associated with mortality in hospitalized patients with SARS-CoV-2 infection. A prospective, longitudinal, unicenter study in Reus, Spain
date: 2020-05-29
journal: bioRxiv
DOI: 10.1101/2020.05.29.122986
sha: dc630096563ccd729b911f098eae7aa2ce380cc4
doc_id: 919758
cord_uid: u7gbzyvx

Spain is one of the countries that has suffered the most from the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the strain that causes coronavirus disease 2019 (COVID-19). However, there is a lack of information on the characteristics of this disease in the Spanish population. The objective of this study has been to characterize our patients from an epidemiological point of view and to identify the risk factors associated with mortality in our geographical area. We performed a prospective, longitudinal study on 188 hospitalized cases of SARS-Cov-2 infection in Hospital Universitari de Sant Joan, in Reus, Spain, admitted between 15th March 2020 and 30th April 2020. We recorded demographic data, signs and symptoms and comorbidities. We also calculated the Charlson and McCabe indices. A total of 43 deaths occurred during the study period. Deceased patients were older than the survivors (77.7 ± 13.1 vs. 62.8 ± 18.4 years; p < 0.001). Logistic regression analyses showed that fever, pneumonia, acute respiratory distress syndrome, diabetes mellitus and cancer were the variables that showed independent and statistically significant associations with mortality. The Charlson index was more efficient than the McCabe index in discriminating between deceased and survivors. This is one of the first studies to describe the factors associated with mortality in patients infected with SARS-CoV-2 in Spain, and one of the few in the Mediterranean area. We identified the main factors independently associated with mortality in our population. Further studies in are needed to complete and confirm our findings.

In January 2020, a new type of coronavirus was identified as the causative factor in a series of March [4] . The incubation period for SARS-CoV-2 ranges from 5 to 6 days on average, with cases 52 being possible from 0 to 14 days [5] . The most common period of transmission of the virus 53 begins 1-2 days before the onset of symptoms, and lasts for up to 5-6 days after the onset of 54 symptoms [6] . The basic reproductive rate R (the average of new cases secondary to a primary 55 case) in our country is, at the time of writing, estimated to be <1; globally, the R number ranges 56 from 0 to 6 depending on various factors, in particular the political and public health measures 57 imposed by the various governments that focus on complete cleaning of public spaces and a 58 decrease in contact between individuals [7] . Identifying the epidemiological characteristics of 59 this disease will help appropriate decisions to be made and thus to control the epidemic. Certain 4 60 clinical symptoms of COVID-19 have been reported previously. The most frequent are: fever, dry 61 cough, asthenia, expectoration, dyspnea, sore throat, headache, myalgia, arthralgia, chills, 62 nausea or vomiting, nasal congestion, diarrhea, hemoptysis and conjunctival congestion (from 63 highest to lowest frequency) [8, 9] 

During the study period, a total of 188 patients were hospitalized for SARS-CoV-2 infection. The the diagnostic accuracy of the ROC curves of these indices in their ability to discriminate 136 between deceased patients and survivors, we found that Charlson index was more efficient, 137 with higher values of the area under the curve (Fig. 3) .

Finally, since the different symptoms and comorbidities can be mutually interdependent 139 and present cause-effect relationships between them, we wanted to identify which factors were 8 140 independently associated with mortality. Logistic regression analyses showed that the presence 141 of fever, pneumonia, acute respiratory distress syndrome, type 2 diabetes mellitus and cancer 142 were the only variables that showed an independent and statistically significant association with 143 mortality when they were adjusted for differences in age, gender, smoking status and alcohol 144 intake (Tables 2 and 3) . 

Most of our patients were over 60 years old and mortality was very high (47.0%) among 153 those over 80 years old. These results are consistent with those published so far, which show 154 that age is one of the most important risk factors for . It is accepted that age is 155 a risk factor for respiratory diseases [19, 23, 24] and impairment of immune function associated 156 with age has been identified as a major cause of high mortality due to severe pneumonia [23] .

Among the signs and symptoms of the disease, we found that fever, pneumonia, and acute 158 respiratory distress syndrome were the only factors independently associated with mortality 159 when adjusted for age, smoking and alcohol intake. These factors are among those that have 9 160 been most frequently found in patients with COVID-19 in most of the studies conducted in 161 China [19, 25, 26] . We did not observe any independent relationship between cough, chills or 162 gastrointestinal disturbances and mortality, despite being present in a relatively high proportion 163 of subjects, something which differs from what has been published previously [19] .

The comorbidities showing a significant relationship with mortality were type 2 diabetes 165 mellitus and cancer. We did not find any independent association with any other chronic 166 metabolic disease, such as cardiovascular disease or others. The univariate analysis showed a 167 high number of patients with these chronic alterations and the logistic regression analysis 168 identified diabetes as the most relevant. Indeed, all of these metabolic diseases are closely 169 related. Diabetes is a causative factor of hypertension and metabolic syndrome and these, in 170 turn, can cause heart, vascular, liver, neurological and kidney diseases. Our study therefore 171 suggests that diabetes might be a triggering factor for these disorders and therefore is related 172 to mortality in patients infected with SARS-CoV-2. Type 2 diabetes mellitus has also been 173 reported to be one of the most important factors related with COVID-19 severity in previous 174 investigations conducted in China, Israel and Italy [25, [27] [28] [29] . Indeed, the Italian study reported 175 that 2/3 of the patients who died were diabetic [29] . Furthermore, diabetes is linked to a higher 176 mortality in other viral infections, such as those caused by influenza A(H1N1), MERS-CoV and 177 SARS-CoV viruses [30, 31] . We also found a close relationship between cancer and COVID-19 178 mortality. One aspect that caught our attention is that, despite our hospital being the reference 179 center for Oncology in our province, the number of cancer patients infected with COVID-19 was 

Gram-negative bacteremia. I. Etiology and ecology

Emotional support and survival after myocardial 283 infarction. A prospective, population-based study of the elderly

Modified IDSA/ATS minor criteria 286 for severe community-acquired pneumonia best predicted mortality

Pneumonia in the elderly: A review of the epidemiology

pathogenesis, microbiology, and clinical features

Pneumonia in the elderly: understanding the characteristics

Clinical findings of patients with 312 coronavirus disease

Imaging and clinical features of patients 316 with 2019 novel coronavirus SARS-CoV-2

Clinical 319 characterization of 162 COVID-19 patients in Israel: Preliminary report from a large 320 tertiary center

COVID-19 and diabetes mellitus: May old anti-322 diabetic agents become the new philosopher's stone?

COVID-19 and Italy: what next?

Prevalence of diabetes in the 2009 influenza A (H1N1) and the

Middle East respiratory syndrome coronavirus: A Systematic review and meta-analysis

Plasma glucose levels and diabetes are 330 independent predictors for mortality and morbidity in patients with SARS

Use of 333 corticosteroids in coronavirus disease 2019 pneumonia: A systematic review of the 334 literature

SARS-CoV-2 transmission in patients with cancer at a 336 tertiary care hospital in Wuhan, China

Clinical characteristics of COVID-19-339 infected cancer patients: a retrospective case study in three hospitals within Wuhan

Risk of COVID-19 for patients with cancer

COVID-19 and cancer: what we know so far

Systematic review of the prevalence of current 347 smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic 348 option?

Beyond smoking cessation: Investigating 351 medicinal nicotine to prevent and treat COVID-19